BILL CHALLENGES SECRECY OVER DRUG SAFETY

被引：0

|

作者：

WEBB, J

机构：

来源：

NEW SCIENTIST | 1992年 / 135卷 / 1832期

关键词：

D O I：

暂无

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

收藏

页码：5 / 5

页数：1

相关论文

共 50 条

[21] DRUG BILL
RUSSELL, T
BRITISH MEDICAL JOURNAL, 1977, 2 (6095): : 1158 - 1158
[22] SAFETY CONCERNS OVER AN OSTEOPOROSIS DRUG
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2011, 111 (11) : 23 - 24
[23] THE DRUG BILL
不详
LANCET, 1953, 265 (NOV28): : 1154 - 1154
[24] THE DRUG BILL
ADAMS, D
NEW ZEALAND MEDICAL JOURNAL, 1983, 96 (742) : 811 - 811
[25] DRUG BILL
SPENCE, AW
BRITISH MEDICAL JOURNAL, 1962, (5311): : 1058 - &
[26] THE DRUG BILL
不详
LANCET, 1959, 1 (MAY2): : 926 - 926
[27] Retrospective Analysis of Outcomes and Safety of Drug Challenges
Kavosh, E. R.
Gruchalla, R. S.
Khan, D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB119 - AB119
[28] THE OPPORTUNITIES AND CHALLENGES OF METABOLOMICS IN DRUG SAFETY EVALUATION
Ma, Xiaochao
DRUG METABOLISM REVIEWS, 2015, 47 : 17 - 17
[29] Pharmacovigilance and Drug Safety: Practical Difficulty and Challenges
Sud, S. S.
Sud, K. S.
DRUG SAFETY, 2016, 39 (10) : 1023 - 1024
[30] Drug safety in developing countries: Achievements and challenges
Shankar, P. Ravi
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (09): : 1323 - 1323

← 1 2 3 4 5 →